[Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].

Pan Afr Med J

Service d'Oncologie Médicale, CHU Hassan II, Route de Sidi Harazem, Fès, Morocco.

Published: November 2019

Paraneoplastic neurologic degeneration (PND) is characterized by acute and subacute onset neurological syndrome associated with active or with subclinical cancer. It is rare but early diagnosis can improve the neurological and carcinological prognosis. Among the PNDs it is possible to distinguish subacute cerebellar degeneration often associated with gynecological or breast cancer. We report the case of a 50-year old female patient on follow-up for ovarian adenocarcinoma treated with surgery and whose recurrence was detected due to anti-Yo antibody-positive subacute cerebellar degeneration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815481PMC
http://dx.doi.org/10.11604/pamj.2019.33.281.17711DOI Listing

Publication Analysis

Top Keywords

neurologic degeneration
8
subacute cerebellar
8
cerebellar degeneration
8
[paraneoplastic neurologic
4
degeneration
4
degeneration revealing
4
revealing ovarian
4
ovarian cancer
4
cancer recurrence]
4
recurrence] paraneoplastic
4

Similar Publications

Alzheimer's disease (AD) is the leading cause of morbidity and mortality worldwide, as a result of cognitive decline and neurological dysfunction. In AD, reduced cerebral blood flow and impaired vascularization result from capillary bed degeneration and decreased angiogenesis, as observed in both patients and animal models. Physical exercise is recognized as a potential intervention to delay AD progression and reduce disease risk.

View Article and Find Full Text PDF

Introduction: Individuals with Down syndrome (DS) exhibit neurological deficits throughout life including the development of in Alzheimer's disease (AD) pathology and cognitive impairment. At the cellular level, dysregulation in neuronal gene expression is observed in postmortem human brain and mouse models of DS/AD. To date, RNA-sequencing (RNA-seq) analysis of hippocampal neuronal gene expression including the characterization of discrete circuit-based connectivity in DS remains a major knowledge gap.

View Article and Find Full Text PDF

Neurodegenerative Disease: From Molecular Basis to Therapy, 2nd Edition.

Int J Mol Sci

February 2025

Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.

Neurodegenerative diseases, characterised by the progressive degeneration of neurons, are a heterogeneous group of largely age-related disorders that affect millions of people worldwide [...

View Article and Find Full Text PDF

Background: Therapeutic development for frontotemporal dementia (FTD) is hindered by the lack of biomarkers that inform susceptibility/risk, prognosis, and the underlying causative pathology. Blood glial fibrillary acidic protein (GFAP) has garnered attention as a FTD biomarker. However, investigations of GFAP in FTD have been hampered by symptomatic and histopathologic heterogeneity and small cohort sizes contributing to inconsistent findings.

View Article and Find Full Text PDF

TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish models.

Cell Death Discov

March 2025

Laboratory of Translational Research for Neurological Disorders, Imagine Institute, INSERM UMR 1163, Université Paris Cité, 75015, Paris, France.

Pathogenic mutations within the TBK1 gene leading to haploinsufficiency are causative of amyotrophic lateral sclerosis (ALS). This gene is linked to autophagy and inflammation, two cellular mechanisms reported to be dysregulated in ALS patients, although its functional role in the pathogenesis could involve other players. We targeted the TBK1 ortholog in zebrafish, an optimal vertebrate model for investigating genetic defects in neurological disorders.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!